Botulinum neurotoxins (BoNTs) are a family of bacterial toxins causing botulism in humans and animals. They are one of the six most dangerous potential bioterrorism threats and are also utilized to treat a variety of human diseases ranging from muscle spasms to chronic pain. BoNTs are known to act by cleaving neuronal proteins essential for synaptic vesicle exocytosis, thereby blocking neurotransmission. Because neurotransmission is not required for survival of neuronal cells, BoNTs are considered not to have any cytotoxicity to neuronal cells. However, a significant portion of patients surviving severe botulism have reported persistent residual symptoms, raising the possibility that BoNTs may have additional long-term adverse effects in neurons beyond their acute action on synaptic vesicle exocytosis. Indeed, our preliminary studies indicated that members of the BoNTs can induce degeneration of neurons. These findings raise the need to investigate the potential cytotoxic effects of BoNTs on neurons in order to fully understand the long-term effects of botulism and to ensure the safe use of BoNTs. Here we propose to carry out the first in-depth study to investigate the cytotoxicity of BoNTs at the molecular and cellular levels. Using cultured hippocampal neurons as a cell model, we will first screen all known BoNTs to identify the ones that can induce degeneration of neurons. We will then evaluate the physiological and human relevance of their cytotoxicity using rodent motor neuron models in vitro and in vivo, and human motor neurons derived from embryonic stem cells. Finally, we will define the molecular basis for BoNT-induced neurodegeneration by identifying the toxin-target proteins and determining the essential cellular process whose disruption leads to neurodegeneration. These proposed studies will uncover and characterize a novel long-term consequence of BoNT action in neurons and lay the foundation for understanding a critical cellular process essential for neuronal survival.

Public Health Relevance

Botulinum neurotoxins are one of the six most dangerous potential bioterrorism threats, and are also widely used to treat many human diseases. The aim of this application is to explore whether members of this toxin family have additional cytotoxic effects in neurons in addition to their well-established action of blocking neurotransmitter release. These studies will identify the potential long-term adverse effects of botulinum neurotoxins, and ensure the safety of their medical applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI097834-01
Application #
8524253
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Ranallo, Ryan
Project Start
2012-08-20
Project End
2014-08-19
Budget Start
2012-08-20
Budget End
2014-08-19
Support Year
1
Fiscal Year
2012
Total Cost
$437,500
Indirect Cost
$187,500
Name
Harvard University
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Peng, Lisheng; Adler, Michael; Demogines, Ann et al. (2014) Widespread sequence variations in VAMP1 across vertebrates suggest a potential selective pressure from botulinum neurotoxins. PLoS Pathog 10:e1004177
Lee, Kwangkook; Zhong, Xiaofen; Gu, Shenyan et al. (2014) Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344:1405-10
Berntsson, Ronnie P-A; Peng, Lisheng; Dong, Min et al. (2013) Structure of dual receptor binding to botulinum neurotoxin B. Nat Commun 4:2058
Peng, Lisheng; Liu, Huisheng; Ruan, Hongyu et al. (2013) Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival. Nat Commun 4:1472
Berntsson, Ronnie Per-Arne; Peng, Lisheng; Svensson, Linda Marie et al. (2013) Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II. Structure 21:1602-11